How were FluoroPharma Medical's earnings last quarter?

FluoroPharma Medical, Inc. (OTCMKTS:FPMI) released its earnings results on Friday, August, 14th. The biopharmaceutical company reported ($0.05) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.06) by $0.01.

What other stocks do shareholders of FluoroPharma Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other FluoroPharma Medical investors own include Adicet Bio (ACET) , AB Corporate Bond ETF (EYEG) , Designer Brands (DBI) , Capricorn Energy (CNE) , Comcast (CMCSA) , Casey's General Stores (CASY) , Axos Financial (AX) and Argos Therapeutics (ARGSQ) .

How do I buy shares of FluoroPharma Medical?

Shares of FPMI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:FPMI

FluoroPharma Medical (FPMI) Stock Price, News & Analysis

→ Elon Musk’s ChatGPT Could Soon Mint New Millionaires (From InvestorPlace) (Ad)

Free FPMI Stock Alerts

Compare

Today's Range: N/A
50-Day Range: N/A
52-Week Range: N/A

Volume: N/A
Average Volume: N/A
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Financials SEC Filings

Get FluoroPharma Medical alerts:

Ad InvestorPlace

Elon Musk’s ChatGPT Could Soon Mint New Millionaires

Elon Musk made $180 million on PayPal… $47 Billion on SpaceX…and $94.2 Billion on Tesla. He’s about to shock the world again with his version of ChatGPT.

And you could go along for the ride if you make this one simple move.

About FluoroPharma Medical Stock (OTCMKTS:FPMI)

FluoroPharma Medical, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of molecular imaging pharmaceuticals with initial applications in the area of cardiology in the United States. Its product candidates include BFPET, an imaging agent that has completed a Phase I clinical trial in stress-testing for patients with presumptive or proven coronary artery disease (CAD); and CardioPET, a molecular imaging agent, which is in Phase IIa clinical trial to assess myocardial blood flow and metabolism in patients with CAD. The company has license agreements with Massachusetts General Hospital and Sinotau USA; and clinical research agreements with Pharmaceutical Product Development, LLC, as well as Cardiovascular Imaging Technologies. FluoroPharma Medical, Inc. was founded in 2003 and is headquartered in Montclair, New Jersey.

Ad InvestorPlace

Elon Musk’s ChatGPT Could Soon Mint New Millionaires

Elon Musk made $180 million on PayPal… $47 Billion on SpaceX…and $94.2 Billion on Tesla. He’s about to shock the world again with his version of ChatGPT.

And you could go along for the ride if you make this one simple move.

FPMI Stock News Headlines

April 9, 2024 | americanbankingnews.com

FluoroPharma Medical (OTCMKTS:FPMI) Stock Passes Above Fifty Day Moving Average of $0.00

July 19, 2023 | msn.com

New 'Fluoro Fentanyl' considered 5 times more potent than normal dose, report says

April 16, 2024 | InvestorPlace (Ad)

REVEALED: Elon Musk’s Secret A.I. Facility?

I recently shot this video outside what could be Elon Musk’s biggest secret. What’s happening inside these walls is so important that our government has declared it a matter of national security.

August 30, 2022 | reuters.com

FluoroPharma Medical Inc

January 19, 2022 | nasdaq.com

FluoroPharma Medical Inc (FPMI)

See More Headlines

Receive FPMI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for FluoroPharma Medical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 8/14/2015
Today: 4/16/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Diagnostic substances
Sub-Industry: N/A
Current Symbol: OTCMKTS:FPMI
CUSIP: N/A
CIK: 1402785
Web: www.fluoropharma.com
Phone: (973) 744-1565
Fax: N/A
Employees: 4
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: 27,580,000
Free Float: 17,401,000
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

5G Stocks: The Path Forward is Profitable

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

Dr. Thomas H. Tulip Ph.D. (Age 71)
CEO, President & Director
Comp: $320k
Ms. Tamara Rhein (Age 52)
Chief Financial Officer
Comp: $130k
Mr. Edward L. Lyons Jr.
Vice President of Development

Key Competitors

View All Competitors

FPMI Stock Analysis - Frequently Asked Questions

How were FluoroPharma Medical's earnings last quarter?: FluoroPharma Medical, Inc. (OTCMKTS:FPMI) released its earnings results on Friday, August, 14th. The biopharmaceutical company reported ($0.05) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.06) by $0.01.
What other stocks do shareholders of FluoroPharma Medical own?: Based on aggregate information from My MarketBeat watchlists, some companies that other FluoroPharma Medical investors own include Adicet Bio (ACET), AB Corporate Bond ETF (EYEG), Designer Brands (DBI), Capricorn Energy (CNE), Comcast (CMCSA), Casey's General Stores (CASY), Axos Financial (AX) and Argos Therapeutics (ARGSQ).
How do I buy shares of FluoroPharma Medical?: Shares of FPMI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:FPMI) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial